近年来中药不良反应特别是传统无毒中药的肝损伤问题屡有报道,引起人们对中药安全性的严重担忧,与此同时传统无毒中药肝损伤的客观性在业内外也存在巨大争议。如何科学认知传统无毒中药的肝损伤已成为本领域最具挑战性的国际性难题。既往研究多拘泥于从药物角度寻找毒性物质及致毒机制,对可能由患者机体因素,特别是机体免疫介导的中药特异质型肝损伤鲜有关注和研究。笔者对中药肝损伤客观辨识与评价中存在的问题进行分析,阐述机体免疫与药物特异质型肝损伤的关系,同时以传统无毒中药何首乌为例,分析其诱导的免疫特异质肝损伤的客观真实性及其机制,在此基础上笔者课题组首次提出了中药特异质肝损伤免疫应激“三因致毒”机制假说,为传统无毒中药肝毒性的客观辨识和评价提供了理论依据,创新和发展了中药安全性评价模式和方法,对于揭示中药肝毒性的客观性具有重要的价值。
Abstract
In recent years, the report of adverse reaction of traditional Chinese medicine(TCM), especially the traditional non-toxic TCM-induced liver injury problems have been repeatedly arising, causing serious concerns about the safety of TCM from the public, and meanwhile there is a huge controversy about the objectivity of traditional non-toxic TCM-induced liver injury as well. How to scientifically acknowledge the side effects of traditional non-toxic TCM has become one of the most challenging and difficult international problems in this field. Previous studies may only focus on the search for toxic substances and toxic mechanisms from the perspective of drugs, so there is little attention and research on the factors that it may be caused by patients′ bodies, especially the immune-mediated idiosyncratic drug induced liver injury. This paper carries on the analysis to the TCM-induced liver injury from the angles of objective identification and evaluation problems, elaborates the relationship between the immune and drug-induced liver injury,taking the traditional non-toxic TCM Polygonum Multiflorum as an example to analyze the objective authenticity and mechanism of immune-mediated idiosyncratic drug induced liver injury, on which basis the immunological stress “Three Factors Causing toxicity” mechanism hypothesis of idiosyncratic TCM-induced liver injury has been frist put forward. This hypothesis also provides a theoretical basis for the objective identification and evaluation of traditional non-toxic TCM-induced liver injury, innovate and develop a new evaluation model and method of TCM′s safety, which has a significant value for revealing the objectivity of TCM-induced liver injury.
关键词
传统无毒中药 /
中药特异质肝损伤 /
何首乌 /
免疫应激 /
机制假说
{{custom_keyword}} /
Key words
traditional non-toxictraditional Chinese medicine /
idiosyncratic TCM-induced liver injury /
Polygonum multiflorum /
immunological stress /
mechanism hypothesis
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] YE Z G, ZHANG G P. Progress of safety evaluation of traditional chinese medicines and its strategy in further studies . Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2014, 20(16):1-6.
[2] NAM S W, BAEK J T, LEE D S, et al. A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia. Clin Toxicol(Phila), 2005,43(6):589-591.
[3] HE Q, TAN B H. Liver injury caused by epimedium in HBV carriers:a case report. Chin J Liver Dis(Electr Ver)(中国肝脏病杂志电子版), 2015,7(1):113-114.
[4] ZHANG L, YANG X H,DENG Y Y. Evaluation and consideration on safety information abroad of Polygonum multiflorum and its preparations. . China J Chin Mater Med(中国中药杂志), 2009, 34(18):2414-2418.
[5] ZHOU L, WANG B M. Advances in study on immunological factors in drug-induced liver injury. Chin J Gastroenterol(胃肠病学), 2014, 19(11):641-643.
[6] AMACHER D E. The primary role of hepatic metabolism in idiosyncratic drug-induced liverinjury. Expert Opin Drug Metab Toxicol, 2012, 8(3): 335-347.
[7] ZHANG X, LIU F, CHEN X, et al. Involvement of the immune system in idiosyncratic drug reactions. Drug Metab Pharmacokinet, 2011, 26(1): 47-59.
[8] CHEN C W. Pay attention to the study of immunological mechanism of drug-induced liver injury. Chine Hepatol(肝脏), 2016, 2(5):397-398.
[9] GU L W, ZHU Q, LI X D, et al. Progress in influence factors on drug induced liver injury. Chin Pharm J(中国药学杂志), 2016, 51(8):607-611.
SU Y J, JIANG Z Z, ZHANG Y, et al. Advances in researches on idiosyncratic drug induced liver injury and its occurrence mechanism. Prog Pharm Sci(药学进展), 2012,36(12): 547-551.
HUANG J F, JIANG Z Z, WANG T, et al. Overview of research on drug-induced liver injury . Prog Pharm Sci(药学进展), 2008, 32(8): 357-362.
NI L, ZHANG B. Study on toxicity theory of Chinese materia medica based on organism state. China J Tradit Chin Med Pharm(中华中医药杂志), 2009, 24(5): 549-551.
WANG Y H, ZHAO H P, WANG J B, et al. Study on dosage-toxicity /efficacy relationship of prepared rhubarb onbasis of symptom-based prescription theory. China J Chin Mater Med(中国中药杂志), 2014, 39(15): 2918-2923.
PANG J Y, BAI Z F, NIU M, et al. The toxic and protective effects of Polygonum multiflorum on normal andliver injured rats based on the symptom-based prescription theory . Acta Pharm Sin(药学学报), 2015, 50(8): 973-979.
WANG J B, XIAO X H, DU X X, et al. Identification and early diagnosis for traditional Chinese medicine-inducedliver injury based on translational toxicology . China J Chin Mater Med(中国中药杂志), 2014, 39(1):5-9.
WANG J B, LI C Y, ZHU Y, et al. Integrated evidence chain-based identification of Chineseherbal medicine-induced hepatotoxicity and rational usage: exemplification by Polygonum multiflorum(He shou wu) . Chin Sci Bull(科学通报), 2016, doi: 10. 1360/N972015-01289.
WANG J B, ZHAO H P, ZHAO Y L, et al. Hepatotoxicity or hepatoprotection pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury. PLoS One, 2011, 6(9): e24498.
ZHU Y, LIU S H, WANG J B, et al. Clinical analysis of drug-induced liver injury caused by Polygonum multiflorum and its preparations . Chin J Integr Tradit and West Med(中国中西医结合杂志), 2015, 35(12): 1442-1447.
WANG J B, MA Z J, NIU M, et al. Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum. Front Med, 2015, 9(4): 457-468.
ZHU Y,NIU M, CHEN J, et al. Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. J Gastroenterol Hepatol,2016, 31(8):1476-1482.
DONG Q, LI N, LI Q, et al. Screening for biomarkers of liver injury induced by Polygonum multiflorum: a targeted metabolomic study. Front Pharmacol, 2015, 6:217.
LI C Y, LI X F, TU C, et al. The idiosyncratic hepatotoxicity of Polygonum multiflorum based on endotoxin model. Acta Pharm Sin(药学学报), 2015, 50(1):28-33.
WANG Q, DAI Z, ZHANG Y J, et al. The research of the hepatotoxicity of Polygonum multiflorum on the basic of the inhibition of the ugt1a1 enzyme in vivo and in vitro. Chin Pharm J(中国药学杂志), 2016, 51(22):1929-1933.
WANG J B, XIAO X H, DU X X, et al. Identification and early diagnosis for traditional Chinese medicine-induced liver injury based on translational toxicology . China J Chin Mater Med(中国中药杂志), 2014, 39(1):5-9.
HUANG Y Y, SUN R, SUN H. Study on the “dosage-time-toxicity” relationship of hepatotoxicity induced by yishenwufa oral liquid in mice. Chin J Pharmacovig(中国药物警戒), 2011, 8(5): 275-278.
QI L I, ZHAO K J, ZHAO Y L, et al. High dosage administration of Polygonum multiflorum alcohol extract caused the multi-organ injury in rats. Global Tradit Chin Med(环球中医药), 2013,6(1): 1-13.
WANG T, WANG J, JIANG Z, et al. Study on hepatotoxicity of aqueous extracts of Polygonum multiforum in rats after 28-day oral administration-analysis on correlation of cholestasis. China J Chin Mater Med(中国中药杂志), 2012, 37(10):1445-1450.
ZHANG S Y, ZHU X G, ZHANG G P, et al. Study on acute and chronic toxicities of Polygoni Multiflori Radix praeparata extracts. J Toxicol(毒理学杂志), 2013, 27(4): 261-264.
ZHU Y, NIU M, CHEN J, et al. Comparison between Chineseherbal medicine and Western medicine-induced liver injury of 1985 patients . J Gastroenterol Hepatol, 2016,31(8):1476-1482.
ZHU Y, LIU S H, WANG J B, et al. Clinical analysis of druginduced liver injury caused by Polygonum multiflorum and its preparations . Chin J Integr Tradit West Med(中国中西医结合杂志), 2015, 35(12): 1442-1447.
CHO T E, UETRECHT J. How reactive metabolites induce an immune response that sometimes leads to an idiosyncratic drug reaction. Chem Res Toxicol, 2016,30(1):295-314.
ROTH R A, GANEY P E. Animal models of idiosyncratic drug-induced liver injury--current status . Critic Rev Toxicol, 2011, 41(9):723-739.
WANG J B, CUI H R, BAI Z F, et al. Precision medicine-oriented safety assessment strategy for traditional Chinese medicines: disease-syndrome-based toxicology. Acta Pharm Sin(药学学报), 2016, 51(11): 1681-1688.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}